Hui G Li

US Patent:

6380189, Apr 30, 2002

Filed:

Feb 11, 2000

Appl. No.:

09/502038

Inventors:

Norman Abood - Morton Grove IL
Daniel L. Flynn - Mundelein IL
Daniel P. Becker - Glenview IL
Brian M. Bax - St. Lcharles IL
Hui Li - Skokie IL
Roger A. Nosal - Buffalo Grove IL
Lori A. Schretzman - Gurnee IL
Clara I. Villamil - Glenview IL

Assignee:

G.D. Searle Co. - Chicago IL

International Classification:

A61K 31536

US Classification:

5142305, 544 92

Abstract:

A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by Formula I wherein R-R are as defined herein, or a pharmaceutically-acceptable salt thereof.

US Patent:

6638952, Oct 28, 2003

Filed:

Dec 23, 1999

Appl. No.:

09/254530

Inventors:

Hui Li - Vernon Hills IL
Daniel P. Becker - Glenview IL
Clara I. Villamil - Glenview IL
Terri L. Boehm - Ballwin MO
Daniel P. Getman - Chesterfield MO
Joseph J. McDonald - Ballwin MO
Gary A. DeCrescenzo - St. Charles MO

Assignee:

Pharmacia Corporation - Skokie IL

International Classification:

A61K 31445

US Classification:

514330, 546221

Abstract:

An aromatic sulfonyl alpha-cycloamino hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a treatment process that comprises administering a contemplated aromatic sulfonyl alpha-cycloamino hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.

US Patent:

6683077, Jan 27, 2004

Filed:

Jan 4, 2002

Appl. No.:

10/035433

Inventors:

Norman Abood - Morton Grove IL
Daniel L. Flynn - Mundelein IL
Daniel P. Becker - Glenview IL
Brian M. Bax - Irvine CA
Hui Li - Vernon Hills IL
Roger A. Nosal - Buffalo Grove IL
Lori A. Schretzman - Gurnee IL
Clara I. Villamil - Glenview IL

Assignee:

G.D. Searle Co. - St. Louis MO

International Classification:

A61K 31535

US Classification:

5142305, 544 92

Abstract:

A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by Formula I wherein R-R are as defined herein, or a pharmaceutically-acceptable salt thereof.

US Patent:

6750233, Jun 15, 2004

Filed:

Sep 17, 2001

Appl. No.:

09/954451

Inventors:

Thomas E. Barta - Evanston IL
Daniel P. Becker - Glenview IL
Louis J. Bedell - Mt. Prospect IL
Terri L. Boehm - Ballwin MO
Jeffery N. Carroll - Collinsville IL
Gary A. DeCrescenzo - St. Charles MO
Yvette M. Fobian - Labadie MO
John N. Freskos - Clayton MO
Daniel P. Getman - Chesterfield MO
Joseph J. McDonald - Ballwin MO
Susan L. Hockerman - Chicago IL
Susan C. Howard - Fenton MO
Steve A. Kolodziej - Ballwin MO
Hui Li - Vernon Hills IL
Deborah A. Mischke - Defiance MO
Joseph G. Rico - Ballwin MO
Nathan W. Stehle - Ballwin MO
Michael B. Tollefson - OFallon MO
William F. Vernier - St. Louis MO
Clara I. Villamil - Glenview IL

Assignee:

Pharmacia Corporation - St. Louis MI

International Classification:

A61K 31382

US Classification:

514336, 514252, 514342, 514383, 514432, 544374, 5462801, 5482658, 549 28

Abstract:

A treatment process is disclosed that comprises administering an effective amount of an aromatic sulfone hydroxamic acid that exhibits excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibition at least of MMP-1 to a host having a condition associated with pathological matrix metalloprotease activity. Also disclosed are metalloprotease inhibitor compounds having those selective activities, processes for manufacture of such compounds and pharmaceutical compositions using an inhibitor.

US Patent:

7552044, Jun 23, 2009

Filed:

Sep 22, 2006

Appl. No.:

11/525690

Inventors:

Minglei Xu - Bellevue WA, US
Avinash Pillai - Redmond WA, US
Hui Li - Redmond WA, US
Paul Trunley - Bellevue WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 9/44

US Classification:

703 20, 703 22, 714 42

Abstract:

Aspects of the subject matter described herein relate to simulating storage devices. In aspects, a test automation engine instructs a simulator to simulate a storage device having certain characteristics such as a storage area network. The test automation engine then tests an application against the simulated storage device. Tests may include storage management requests and storage access requests. A provider may translate a request to one or more operations suitable to perform the request on the underlying simulated device. Shadow copies and the results of other storage management-related operations may be shared across computers via aspects of a simulation framework described herein.

US Patent:

7783677, Aug 24, 2010

Filed:

Sep 10, 2007

Appl. No.:

11/852351

Inventors:

Hui Li - Redmond WA, US
Sarosh Cyrus Havewala - Kirkland WA, US
Neal R Christiansen - Bellevue WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 17/30

US Classification:

707803, 707695

Abstract:

Aspects of the subject matter described herein relate to tracking file system namespace changes during transactions. In aspects, a filter monitors operations that may affect a tracked portion of a transactional file system's namespace. When an operation that affects the tracked portion is received, a data structure is modified to track the changes. Nodes within the data structure are marked to indicate whether they can be seen inside or outside of the transaction. If the transaction commits or rolls back, nodes within the data structure are deleted and made visible as appropriate.

US Patent:

7848558, Dec 7, 2010

Filed:

Feb 13, 2004

Appl. No.:

10/777041

Inventors:

Maryellen L. Giger - Elmhurst IL, US
Hui Li - Chicago IL, US

Assignee:

The University of Chicago - Chicago IL

International Classification:

G06K 9/00

US Classification:

382132, 382155, 382129

Abstract:

A computerized method, system and computer program for the computerized fractal-based analysis of a structure as presented in a pattern on a medical image. Image data is generated from the medical image and a region of interest is selected. The image data is digitized and analyzed to reveal fractal-based computer-generated features of a texture of the image data. Then a qualifier is applied to the computer-generated features to obtain fractal characteristics of the image data. A multi-fractal nature is observed for the texture of the region of interest. A marker for assessing a risk of a disease is yielded based on the multi-fractal nature of the texture.

US Patent:

7877424, Jan 25, 2011

Filed:

Sep 10, 2007

Appl. No.:

11/852352

Inventors:

Sarosh Cyrus Havewala - Kirkland WA, US
Hui Li - Redmond WA, US
Neal R Christiansen - Bellevue WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 17/30

US Classification:

707826

Abstract:

Aspects of the subject matter described herein relate enforcing quotas in transactional file systems. In aspects, a filter monitors operations that may affect quota usage/charge of a file system object having a quota allotment. In doing so, the filter determines a quota value outside of any transaction for the object and a quota value associated with at least one transaction affecting the object. The filter receives a request that involves the use of additional quota. The filter then determines whether to allow or fail the request depending on whether enough quota is available to satisfy the request.